Diprobase Cream

Diprobase is a well-established medical skin care brand that has specialized in treating dry skin conditions, eczema, and dermatitis for over three decades. Originally developed as a therapeutic emollient for clinical and home use, it gained a strong reputation for its ability to create a protective barrier on the skin, locking in moisture and shielding against external irritants.

The brand was historically associated with Schering-Plough and later Merck & Co. (known as MSD outside the US) following their merger. However, as part of a strategic shift in the pharmaceutical industry to separate consumer healthcare from prescription medicine, the brand was acquired by Bayer. Bayer subsequently divested several dermatology brands, leading to its current ownership structure.

Today, Diprobase is part of the Karo Healthcare portfolio. Karo Healthcare, headquartered in Sweden, focuses on everyday healthcare products and has expanded Diprobase's reach across European markets. While the brand originated in the pharmaceutical sectors of the US/UK, it is now a staple of European consumer health, with manufacturing occurring at various specialized dermatological production sites across the continent to meet international demand.